Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
China · Delayed Price · Currency is CNY 5.83
+0.11 (1.92%)
Aug 20, 2026, 3:04 PM CST
SHE:002370 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,347 | 5,451 | 2,174 | 2,421 | 2,640 | 2,404 | |
Market Cap Growth | -19.36% | 150.71% | -10.21% | -8.29% | 9.84% | 19.48% |
Enterprise Value | 3,731 | 4,833 | 2,092 | 2,578 | 2,878 | 2,567 |
Last Close Price | 5.83 | 7.31 | 3.05 | 4.29 | 4.92 | 4.48 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 42.49 | 56.60 | 63.50 | - | - | - |
Forward PE | - | 39.30 | 39.30 | 39.30 | 39.30 | 39.30 |
PS Ratio | 13.66 | 16.87 | 5.37 | 5.76 | 7.07 | 7.63 |
PB Ratio | 3.89 | 4.87 | 2.24 | 4.17 | 8.77 | 5.55 |
P/TBV Ratio | 4.04 | 5.06 | 2.37 | 4.64 | 10.82 | 6.30 |
P/FCF Ratio | 511.17 | 228.61 | 150.61 | 336.67 | - | - |
P/OCF Ratio | 287.47 | 188.63 | 89.28 | 165.27 | 219.30 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 11.73 | 14.96 | 5.16 | 6.13 | 7.71 | 8.15 |
EV/EBITDA Ratio | - | - | 74.92 | 469.20 | 649.86 | - |
EV/FCF Ratio | 438.68 | 202.69 | 144.90 | 358.37 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | - | - | 0.34 | 1.19 | 3.16 | 2.25 |
Debt / EBITDA Ratio | - | - | 11.88 | 121.14 | 169.35 | - |
Debt / FCF Ratio | - | - | 22.98 | 95.87 | - | - |
Net Debt / Equity Ratio | -0.55 | -0.55 | -0.42 | -0.05 | 0.64 | 0.35 |
Net Debt / EBITDA Ratio | 188.25 | 360.09 | -14.76 | -5.63 | 43.85 | -1.73 |
Net Debt / FCF Ratio | -72.49 | -25.95 | -28.55 | -4.30 | -21.44 | -7.81 |
Asset Turnover | 0.24 | 0.24 | 0.29 | 0.28 | 0.24 | 0.18 |
Inventory Turnover | 2.46 | 2.58 | 3.56 | 3.13 | 3.17 | 3.34 |
Quick Ratio | 6.84 | 5.09 | 2.09 | 5.32 | 4.00 | 4.24 |
Current Ratio | 7.91 | 5.90 | 2.29 | 5.90 | 4.52 | 4.65 |
Return on Equity (ROE) | 9.60% | 9.21% | 4.41% | -2.69% | -36.14% | -41.76% |
Return on Assets (ROA) | -1.30% | -1.34% | -0.40% | -1.40% | -1.44% | -4.59% |
Return on Invested Capital (ROIC) | -5.56% | -5.42% | -1.61% | -6.32% | -6.65% | -20.58% |
Return on Capital Employed (ROCE) | -2.50% | -2.60% | -0.90% | -2.60% | -2.80% | -9.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.34% | 1.77% | 1.57% | -0.49% | -5.03% | -9.50% |
FCF Yield | 0.20% | 0.44% | 0.66% | 0.30% | -0.34% | -0.82% |
Payout Ratio | 36.57% | 38.80% | 34.76% | - | - | - |
Buyback Yield / Dilution | -3.10% | -8.18% | -15.32% | -11.89% | 0.02% | 2.68% |
Total Shareholder Return | -3.10% | -8.18% | -15.32% | -11.89% | 0.02% | 2.68% |